Sharkey, Howes & Javer’s Zimmer Biomet ZBH Stock Holding History

Sharkey, Howes & Javer’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-33	Closed	-$3K	–	222
2018 Q1	$3K	Buy	+33	New	+$3.83K	﹤0.01%	181

Other funds holding ZBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Sharkey, Howes & Javer's ZBH Position: Q2 2018 in Review

Sharkey, Howes & Javer sold out of Zimmer Biomet (ZBH) in Q2 2018, closing a stake of 33 shares — an estimated $3K sold.

Sharkey, Howes & Javer first reported a position in ZBH in Q1 2018 and held it in 1 quarter. The position peaked at $3K in Q1 2018. 869 funds tracked by Wall St. Rank hold ZBH as of Q2 2018.

Sharkey, Howes & Javer reported no remaining Zimmer Biomet position as of Q2 2018 after selling out during the quarter.
Sharkey, Howes & Javer sold 33 Zimmer Biomet shares in Q2 2018, an estimated $3K.
Sharkey, Howes & Javer first reported a position in Zimmer Biomet in Q1 2018 and held it in 1 quarter.
Sharkey, Howes & Javer's Zimmer Biomet position peaked at $3K in Q1 2018.
869 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2018.

Based on Sharkey, Howes & Javer's 13F filing for Q2 2018, filed 26 Jul 2018.